Topical immunization strategies.

Area of Science:

• Vaccinology
• Immunology
• Public Health

Background:

• Numerous vaccine candidates target mucosal infections, yet few are approved for human use.
• Research focuses on new adjuvants, delivery systems (live vectors), and targeting molecules for mucosal vaccines.

Purpose of the Study:

• To highlight critical considerations for developing and implementing mucosal vaccines, particularly in resource-limited settings.
• To emphasize the need for needle-free, topical vaccine administration routes.

Main Methods:

• Review of clinical and field research findings related to mucosal vaccine development and deployment.
• Analysis of challenges in vaccine administration and immune response measurement, especially in infants.

Main Results:

• Few mucosal vaccines are registered, necessitating advancements in adjuvant and delivery system research.
• Topical vaccines administered without needles are crucial for accessibility and broad protection.
• Vaccine strategies must account for anatomical immune compartmentalization and specific age groups.

Conclusions:

• Developing safe, effective, and broadly applicable topical mucosal vaccines is essential for global health.
• Route selection for immunization is critical for organ-specific infections, especially in vulnerable populations.
• Addressing challenges in resource-poor settings is key to successful vaccine implementation.